The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast (Q72858691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

title

The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

6 September 2023

author name string

R. J. Santen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6249490

6 September 2023

S. A. Wells

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6249490

6 September 2023

language of work or name

English

0 references

publication date

1 August 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

15 August 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6249490

full work available at URL

6 September 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

6 September 2023

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

6 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

issue

4 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1066-1074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

29 October 2019

cites work

1

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Aminoglutethimide Inhibition of Adrenal Desmolase Activity

6 September 2023

2

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action

6 September 2023

3

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Effects of amino-glutethimide on adrenal function in man.

6 September 2023

4

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications

6 September 2023

6

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Preliminary trial of aminoglutethimide in breast cancer

6 September 2023

7

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Source of Estrogen Production in Postmenopausal Women1

6 September 2023

8

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer

6 September 2023

12

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Tamoxifen in advanced breast cancer

6 September 2023

14

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

6 September 2023

15

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Medical and surgical adrenalectomy in patients with advanced breast carcinoma

6 September 2023

17

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Antithyroid and antiadrenocortical activity of aminoglutethimide

6 September 2023

19

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Goitrous hypothyroidism induced by amino-glutethimide, anticonvulsant drug

6 September 2023

20

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

6 September 2023

22

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels

6 September 2023

23

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma

6 September 2023

24

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer

6 September 2023

27

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

6 September 2023

28

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Compensatory Increase in TSH Secretion without Effect on Prolactin Secretion in Patients Treated with Aminoglutethimide

6 September 2023

29

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Adrenal Suppression with Aminoglutethimide. I. Differential Effects of Aminoglutethimide on Glucocorticoid Metabolism as a Rationale for Use of Hydrocortisone12

6 September 2023

30

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Aminoglutethimide in treatment of metastatic breast carcinoma

6 September 2023

31

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma

6 September 2023

35

1 reference

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

6 September 2023

Identifiers

10.1002/1097-0142(19800815)46:4 <1066::AID-CNCR2820461335>3.0.CO;2-M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6249490 AND SRC:MED&resulttype=core&format=json

29 October 2019

1 reference